Delivery Order SPE2DR25D1200-SPE2DR26FML7R
Award Date 2/17/26
Potential Completion Date 2/18/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $2,975.20 delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 11, 2026. Pricing is firm fixed price under a no-set-aside procurement.</p>
- The Defense Logistics Agency (DLA) awarded a $13,570.85 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (tirzepatide) 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 7, 2025. The pharmaceutical product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $5,651.58 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen injections. This firm fixed-price delivery order is scheduled for completion by January 15, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive basis without set-aside designation, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at approximately $30K to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on December 11, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from the company's Conshohocken, Pennsylvania facility and is scheduled for completion by December 12, 2025. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (tirzepatide) 2.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This firm fixed-price delivery order, valued at $9,394.59, represents a competitive award with no set-aside designation and is set for completion by August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the federal medical...
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $15,289.25 for Zepbound 5 mg/0.5 mL pen (tirzepatide injection).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 11, 2026. No set-aside was used.</p>
- The Defense Logistics Agency (DLA) awarded a $1,172.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 5 mg/0.5 mL pen injections on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling federal pharmaceutical procurement needs for military and veteran healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 mL pen injections. This is a firm fixed-price delivery order valued at $4,007.01, with an ultimate completion date of May 13, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $4,844.24 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 ml pre-filled pens. The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,348.82 to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections on November 24, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a pharmaceutical supply transaction under the company's broader federal contracting...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FML7RDelivery Order
The Defense Logistics Agency issued a $1,607.32 delivery order to AmerisourceBergen Drug Corp on February 17, 2026, for Zepbound 5 mg/0.5 mL pen (tirzepatide injection). The order is placed under an Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with an ultimate completion date of February 18, 2026.
Generated 5/18/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/16/26 |